Nan Ransohoff on X: "Today we're launching Intercept: a $500M philanthropic initiative to make respiratory infections, like the common cold and flu, a thing of the past. We treat respiratory infections as a minor nuisance, but that’s really not the case. Most of us will spend 5% of our lives (!)" / X
Today we're launching Intercept: a $500M philanthropic initiative to make respiratory infections, like the common cold and flu, a thing of the past. We treat respiratory infections as a minor nuisance, but that’s really not the case. Most of us will spend 5% of our lives (!)
Nan Ransohoff @nanransohoff Today we're launching Intercept: a $500M philanthropic initiative to make respiratory infections, like the common cold and flu, a thing of the past. We treat respiratory infections as a minor nuisance, but that’s really not the case. Most of us will spend 5% of our lives (!) sick from these viruses, they kill 1M people a year, cost $600B annually in productivity, and periodically threaten civilization through pandemics. So, if they’re such a big problem, why haven’t we dealt with them yet? Last year we convened ~40 leading scientists, pharma R&D leaders, biotech inv
related reading
- Interceptinterceptfund.com
- There should be ‘general managers’ for more of the world’s important problemsnanransohoff.substack.com
- Surplus — a software incubatorsurplus.dev
- Companies that should exist - Anastasia Gamickanastasiagamick.substack.com
- Anthropic's $5B, 4-year plan to take on OpenAI | TechCrunchtechcrunch.com
- Invest || Trust Fund by Sophia Amorusotrustfund.vc
- Replit: Remix the Internetnotboring.co
- Inception Fund | Menlo Venturesmenlovc.com
- Anti Fundantifund.com
- Fundraising for Founder-led Biotech – Matt Krisiloffmattkrisiloff.com
- Future Vision XPRIZEfuturevisionxprize.com
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com